Related Experiment Video
Updated: Aug 15, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
A multipurpose comorbidity scoring system performed better than the Charlson index
C D'Arcy J Holman1, David B Preen, Natalya J Baynham
1Centre for Health Services Research, School of Population Health, The University of Western Australia, 35 Stirling Highway, MDP M431, Crawley 6009, Australia. darch@dph.uwa.edu.au
A new Multipurpose Australian Comorbidity Scoring System (MACSS) significantly outperforms the Charlson index in predicting patient mortality, readmissions, and length of stay, establishing a new standard for comorbidity risk adjustment.
Area of Science:
- Health Services Research
- Clinical Epidemiology
- Health Informatics
Background:
- The Charlson index is a widely used comorbidity scoring system.
- Existing comorbidity indices may not accurately capture the complexity of patient health status.
- There is a need for improved methods to adjust for comorbidity in health outcomes research.
Purpose of the Study:
- To develop and validate a novel comorbidity scoring system, the Multipurpose Australian Comorbidity Scoring System (MACSS).
- To compare the performance of MACSS against the Charlson index.
- To assess the utility of MACSS in predicting mortality, readmissions, and length of stay.
Main Methods:
- Development of MACSS using population-based cohorts from Western Australia (medical, procedural, psychiatric).
- Identification of 102 comorbid conditions based on association with mortality, readmission, or length of stay.
- Comparative analysis of MACSS and Charlson index performance across five clinical scenarios.
Main Results:
- MACSS demonstrated superior performance compared to the Charlson index across all three outcomes (mortality, readmission, length of stay).
- MACSS improved discrimination for mortality and readmission by 5-40% and increased R-squared for length of stay models up to fourfold.
- MACSS effectively corrected for confounding by comorbidity in effect measures.
Conclusions:
- The Multipurpose Australian Comorbidity Scoring System (MACSS) represents a significant advancement over the Charlson index.
- MACSS offers a more accurate method for adjusting for comorbidity risk in research and clinical practice.
- The adoption of MACSS or similar systems is recommended as a new methodological standard.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...